insights_auto
Why is KROS down 2.62%?
Dive Deeperchevron_right
KROS:NASDAQ
Keros Therapeutics Inc
$10.03
arrow_downward
-2.62%(-0.27) 1D
$10.18
arrow_upward
+1.50% (+0.15)bedtimeAfter hours
Closed: Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KROS...
Open
$10.33
High
$10.74
Low
$9.90
Mkt. cap
196.83M
Avg. vol.
184.55K
Volume
193.90K
52-wk high
$22.55
52-wk low
$8.98
EPS
-$2.83
Beta
1.13
Shares outstanding
19.62M
No. of employees
87
Open
$10.33
High
$10.74
Low
$9.90
Mkt. cap
196.83M
Avg. vol.
184.55K
Volume
193.90K
52-wk high
$22.55
52-wk low
$8.98
EPS
-$2.83
Beta
1.13
Shares outstanding
19.62M
No. of employees
87
News stories
From web sources and news partners
marketscreener.com
·
5 hours ago
Keros Therapeutics Authorizes $5 Million Share Repurchase Program
TradingView
·
6 hours ago
Keros Therapeutics Announces Additional $5 Million Share Repurchase Authorization
Investing.com
·
6 hours ago
Keros Therapeutics approves $5M share buyback program
Zacks
·
12 hours ago
Novartis' Cosentyx Gets Positive CHMP Opinion for Adolescents With HS
About Keros Therapeutics Inc
CEO-
Employees87
Founded2015
HeadquartersLexington, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitekerostx.com